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Allelic loss of the essential autophagy gene beclin1
occurs in human cancers and renders mice tumor-
pronesuggesting that autophagy isa tumor-suppres-
sion mechanism. While tumor cells utilize autophagy
to survivemetabolic stress, autophagy alsomitigates
the resulting cellular damage that may limit tumori-
genesis. In response to stress, autophagy-defective
tumor cells preferentially accumulated p62/SQSTM1
(p62), endoplasmic reticulum (ER) chaperones,
damaged mitochondria, reactive oxygen species
(ROS), and genome damage. Moreover, suppressing
ROS or p62 accumulation prevented damage result-
ing from autophagy defects indicating that failure to
regulate p62 caused oxidative stress. Importantly,
sustained p62 expression resulting from autophagy
defects was sufficient to alter NF-kB regulation and
gene expression and to promote tumorigenesis.
Thus, defective autophagy is a mechanism for p62
upregulation commonly observed in human tumors
that contributes directly to tumorigenesis likely by
perturbing the signal transduction adaptor function
of p62-controlling pathways critical for oncogenesis.
INTRODUCTION
Macroautophagy (autophagy) targets cellular proteins, protein
aggregates and organelles for degradation in lysosomes (Levine
and Kroemer, 2008). Autophagy is induced by starvation or
stress where double membrane vesicles (autophagosomes)
capture intracellular cargo, and then fuse with lysosomes and
are degraded. This lysosome-mediated cellular self-digestion
sustains cell metabolism during starvation and eliminates
damaged proteins and organelles that accumulate during stress.1062 Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc.In mice, autophagy enables survival to neonatal starvation by
preventing energy depletion (Kuma et al., 2004). Brain-targeted
autophagy-deficiency (atg5/ or atg7/) causes damaged
mitochondria and polyubiquitin-containing protein aggregate
accumulation, and neuronal degeneration (Hara et al., 2006;
Komatsu et al., 2006). Liver-targeted autophagy deficiency
(atg7/) similarly results in protein aggregate accumulation,
hepatocyte cell death and liver injury (Komatsu et al., 2005).
These findings support a prosurvival role for autophagy in
sustaining energy homeostasis and maintaining protein and
organelle quality control by eliminating damaged proteins and
organelles during stress and aging (Levine and Kroemer, 2008).
Autophagy is induced by and localizes to hypoxic tumor
regions where it supports cell survival (Degenhardt et al., 2006;
Karantza-Wadsworth et al., 2007; Mathew et al., 2007b). Para-
doxically, autophagy defects due to allelic loss of beclin1 or
constitutive activation of the autophagy-suppressing PI-3
kinase/mTOR pathway are common in human tumors (Levine
and Kroemer, 2008). How loss of autophagy survival promotes
tumor growth is being gradually reconciled (Jin and White,
2007, 2008; Mathew et al., 2007a).
Analogous to a wound-healing response, chronic cell death in
response to stress and induction of inflammation and cytokine
production may provide a non-cell-autonomous mechanism by
which autophagy defects promote tumorigenesis (Degenhardt
et al., 2006). Autophagy-defective tumor cells also display
elevated genome damage with stress, suggesting that damage
mitigation by autophagy is a cell-autonomous mechanism of
tumor suppression (Karantza-Wadsworth et al., 2007; Mathew
et al., 2007a;Mathewet al., 2007b). Possible non-mutually exclu-
sive mechanisms by which autophagy limits cellular damage
include maintenance of energy homeostasis, reduction of oxida-
tive stress, and elimination of damaged proteins and organelles.
The importance of autophagy in cellular garbage disposal is
clear, as autophagy is the only knownmeans for turnover of large
cellular structures such as organelles and protein aggregates
(Levine and Kroemer, 2008). How organelles are recognized
Figure 1. Elevated and Persistent p62 in Autophagy-Defective Tumor Cells under Metabolic Stress
(A) Domain organization of p62 illustrating the Phox andBem1p (PB1) oligomerization domain (p62 and atypical Protein KinaseC [aPKC]), the Zinc finger (ZZ) Rip 1
binding domain, the TRAF6 binding site (TBS), the microtubule associated protein light chain 3 (LC3) domain (LC3/ATG8 binding), and the ubiquitin-associated
(UBA) (poly-ubiquitin binding) domain.
(B) IF of endogenous p62 showing accumulation and persistence of p62 in autophagy-defective cells under normal growth conditions (Day 0), 7 days of metabolic
stress (Day 7I), and 1 (Day 7I+1R) and 2 (Day 7I+1R) days of recovery.
(C) Autophagy-defective cells express constitutively higher levels of exogenous Myc-p62. Six independent cell lines of Bcl-2-expressing atg5+/+ and atg5/
iBMK cells stably expressing Myc-tagged p62 were evaluated for p62 expression levels by Western blotting with an antibody to Myc tag.and directed to autophagosomes for degradation is not known,
butmay involve organelle-specific processes such asmitophagy
and ER-phagy (Bernales et al., 2006; Kim et al., 2007). Damaged
proteins that accumulate during stress can be refolded, ubiquiti-
nated and degraded by the proteasome pathway, or aggregated
and degraded by autophagy. To direct damaged or unfolded
proteins to the autophagy pathway, p62 binds to polyubiquiti-
nated proteins and aggregates by oligomerization, and binds
to Atg8/LC3 on the autophagosome membrane to target aggre-
gates to autophagosomes for degradation (Figure 1A) (Pankivet al., 2007; Wooten et al., 2008). Protein aggregation may be
a protective mechanism to limit cellular exposure to toxic
proteins through sequestration, and an efficient packaging and
delivery mechanism that collects and directs damaged proteins
to autophagosomes. Liver-specific autophagy defects in mice
cause accumulation of p62 aggregates, oxidative stress and
p62-dependent hepatocyte cell death (Komatsu et al., 2007).
Thus, the inability to eliminate p62 through autophagy can be
toxic to normal tissues, but whether this is related to the tumor
suppression by autophagy was not known.Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc. 1063
We report here that metabolic stress caused autophagy-
defective tumor cells to preferentially accumulate p62, ER chap-
erones and protein disulphide isomerases (PDIs), indicative of
protein quality control failure. Moreover, autophagy defects
caused accumulation of damagedmitochondria, elevated oxida-
tive stress and DNA damage response activation, which were
attributed directly to persistence of p62. Cytotoxic effects due
to defective autophagy were suppressed by ROS scavengers
or by p62 elimination, indicating that persistence of p62 and
oxidative stress caused cellular damage. This failure of autoph-
agy-defective cells to eliminate p62 was sufficient to alter
NF-kB regulation and gene expression and to promote tumori-
genesis, indicating that autophagy suppresses tumorigenesis
by limiting p62 accumulation. As p62 is commonly upregulated
in human tumors (Zatloukal et al., 2007), this is at least partially
due to defective autophagy and plays a causal role in cancer.
RESULTS
Autophagy-Defective Tumor Cells Accumulate
p62 in Response to Stress
To address the role of autophagy-dependant protein quality
control in tumor suppression, we assessed p62 modulation
Figure 2. Metabolic Stress Promotes Organelle
Damage and ERChaperones and PDI Upregulation
in Autophagy-Deficient Cells
(A–D) Representative electron micrographs of Bcl-2-
expressing atg5+/+ (A) or atg5/ (B) cells following
7 days of metabolic stress. Bcl-2 expressing atg5+/+
iBMK cell (A) showing mitochondria (M, blue arrows and
C, left panel), ER (E, red arrows and C, right panel), mutant
cell in (B) showingmitochondria (M, blue arrows and D, left
panel), and protein aggregates (A, yellow and D, right
panel).
(E and F) 2-DIGE gels showing differential regulation of ER
chaperones (GRp170, GRp78), PDI, PDI-P4Hb and ACO2
in Bcl-2-expressing atg5/ iBMK cells in response to
metabolic stress (7 days). Total protein from unstressed
or metabolically stressed (7 days) Bcl-2-expressing
atg5+/+ and atg5/ cell lines were labeled with Cy3
(Green-unstressed) or Cy5 (Red-stressed) and analyzed
by 2-DIGE. Images show 2-DIGE gels with proteins that
are induced (Red), repressed (Green) or unchanged
(Yellow) under metabolic stress. Protein spots (n = 106)
that were differentially expressed were selected and iden-
tified by mass spectrometry.
during metabolic stress and recovery in autoph-
agy-competent (beclin1+/+ and atg5+/+) and
-defective (beclin1+/ and atg5/) immortal-
ized baby mouse kidney (iBMK) cells. Cells
were engineered to express Bcl-2, as as-
sessment of autophagy is facilitated in an
apoptosis-defective background and expres-
sion of Bcl-2 is functionally equivalent to loss
of Bax and Bak in the context of autophagy
modulation and tumorigenesis (Degenhardt
et al., 2006; Lum et al., 2005; Nelson et al.,
2004). Under normal growth conditions, endog-
enous p62 levels were low by indirect immunofluorescence (IF) in
beclin1+/+ and atg5+/+ cells and slightly elevated in autophagy-
defective iBMK cells (Figure 1B). Following 7 days of metabolic
stress p62was induced in beclin1+/+ and atg5+/+ cells and further
elevated in autophagy-defective cells in a punctate pattern indic-
ative of aggregation. In beclin1+/+ and atg5+/+ cells, p62 was
eliminated within 24 hr of recovery, whereas p62 persisted in
autophagy-defective cells often in aggregates (Figure 1B).
Higher p62 levels were observed in autophagy-deficient atg5/
as compared to atg5+/+ iBMK cells stably expressing myc-
tagged p62 (myc-p62) (Figure 1C). Thus, metabolic stress-
induced p62 accumulation required autophagy for elimination,
consistent with the absence of p62 gene induction in beclin1+/
and atg5/ tumors (see below).
Autophagy-Defective Tumor Cells Accumulate
Damaged Mitochondria, ER Chaperones, and PDIs
Apoptosis-deficient atg5+/+ iBMK cells respond to prolonged
stress by undergoing progressive autophagy, yielding cells less
than one-third their original size (Degenhardt et al., 2006) with
well-preserved mitochondria (M) and ER (E) (Figures 2A and
2C). In contrast, Bcl-2-expressing atg5/ (Figure 2B) and
beclin1+/ (data not shown) iBMK cells contained mitochondria1064 Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc.
with structural abnormalities (M) and abnormal cytoplasmic
structures (A) resembling protein aggregates (Figures 2B and
2D), consistent with p62 accumulation (Figure 1B). Thus, autoph-
agy functions to prevent accumulation of damaged organelles
and protein aggregates during metabolic stress.
Since tumor cells with defective autophagy displayed failure
of protein quality control, we performed two-dimensional differ-
ence in gel electrophoresis (2-DIGE) coupled with mass
spectrometry to characterize the cellular proteome. Autophagy-
competent, apoptosis-defective (bax//bak/) D3 iBMK cells
manage long-termmetabolic stress by activating autophagy (De-
genhardt et al., 2006) and induced ER chaperones (glucose-
regulated proteins 170 [GRp170 and GRp78] and calreticulin),
PDIs, metabolism and mitochondrial proteins (Table S1). Some
of these proteins (TPI-1, PGK-1, PK-3 and GPDH) are targets of
hypoxia inducible factor-1 a (HIF-1a) indicative of metabolic
adaptation (Table S1), and HIF-1a is induced in iBMK cells
by metabolic stress in vitro and in tumors in vivo (Nelson
et al., 2004). Similarly, Bcl-2-expressing autophagy-competent
beclin1+/+ and atg5+/+ iBMK cells induced ER chaperones
GRp170, GRp78, calreticulin and calnexin indicating that meta-
bolic stress response was independent of the means of
apoptosis inactivation (Figures 2C and 2D and Table S1 available
with this article online). To determine if autophagy status altered
this stress response, Bcl-2-expressing, apoptosis and autoph-
agy-defective (beclin1+/ and atg5/) iBMK cells were similarly
examined. Autophagy-defective cells displayed preferential up-
regulation of ER chaperones compared to beclin1+/+ and atg5+/+
cells (Figures 2E and 2F and Table S1). Allelic loss of beclin1was
associated with a marked, differential increase in GRp170,
GRp78, calreticulin and calnexin while atg5/ cells showed
differential increase in GRp170, GRp78 and calnexin compared
to autophagy-competent controls (Table S1). GRp170 levels
were induced by 3- to 9-fold in autophagy-competent (D3,
beclin1+/+ and atg5+/+) cells whereas induction was 20-fold in
autophagy-deficient (beclin1+/ and atg5/) cells under meta-
bolic stress (Figure 2F and Table S1). A similar but less striking
differential increase in GRp78 was also observed in beclin1+/
and atg5/ cells (Table S1). PDI family members (PDI and PDI-
P4Hb) instrumental in folding proteins in the ER were induced
under metabolic stress and were further elevated by autoph-
agy-deficiency (Figures 2E and 2F and Table S1). The lack of
induction of calreticulin and PDI-P4Hb by metabolic stress in
atg5/ iBMK cells (Table S1) may be due to their increased
susceptibility tometabolic stress (Mathewet al., 2007b). Interest-
ingly, levels of cytoskeletal- and protein synthesis-related
proteins were repressed with stress in all cell lines (Table S1).
This enhanced induction of the protein folding machinery in the
autophagy-deficient cells under stress suggests a role for au-
tophagy in mitigating ER stress by eliminating unfolded proteins
through lysosomal degradation.
As individual proteins can be represented by multiple spots in
2-DIGE, complicating estimation of protein levels by spot volume
ratios, quantitation was validated by Western blotting. p62 and
ER chaperones GRp170, GRp78, calnexin and PDI, showed
higher induction in beclin1+/ and atg5/ compared to
beclin1+/+ and atg5+/+ cells under stress (Figure 3A) consistent
with p62 IF and proteomic analysis. As with p62, elevated orpersistent levels of these proteins were more evident in atg5/
and beclin1+/ cells (Figure 3A), supporting that autophagy
defects elevated demand for protein folding under metabolic
stress that persists during recovery.
Autophagy Defects Cause Sensitivity to ER Stress
Since autophagy defects upregulated protein folding regulators,
we compared the sensitivity of beclin1 cells to pharmacological
induction of ER stress. Tunicamycin induces ER stress by inhibit-
ing protein glycosylation and allelic loss of beclin1 increased
sensitivity to thisdrug (Figure3B). To investigate if autophagydefi-
ciency also elevated the burden on the ubiquitin-proteasome
system, sensitivity to the proteasome inhibitor epoxomicin was
assessed. Autophagy-defects sensitized to proteasome inhibi-
tion, and metabolic stress increased this sensitivity (Figures 3C
and3D) suggestinganelevateddependencyofautophagy-defec-
tive cells on proteasome pathway. Thus, autophagy maintains
protein quality control cooperatively with the ubiquitin-protea-
some pathway, consistent with suppression of proteasome func-
tion activating autophagy, the inhibition of which promotes cell
death (Ding et al., 2007).
Electron Microscopy (EM) revealed preferential accumulation
of morphologically abnormal mitochondria in autophagy-defi-
cient cells (Figures 2A–2D) and stressed atg5/ cells showed
aberrant regulation of mitochondrial proteins such as aconitase
(ACO2) (Figures 2E and 2F) consistent with mitochondrial deteri-
oration. ACO2 is susceptible to mitochondrial oxidative stress
and upon oxidation is either stabilized or degraded (Fariss
et al., 2005). Autophagy-deficient cells showed increased
(beclin1+/) or reduced (atg5/) levels of ACO2 after 7 days of
metabolic stress compared to autophagy-competent controls
(Figure 3E). Furthermore, LON, which degrades the oxidized
form of ACO2 (Fariss et al., 2005), increased under metabolic
stress, as did other oxidative stress markers. The accelerated
deterioration of mitochondria in atg5/ compared to beclin1+/
cells may account for the reduction in ACO2, superoxide dismu-
tase (SOD2) and peroxiredoxin (PRDX3) at 7 days of stress
(Figure 3E). Thus autophagy defects are associated with accu-
mulation of damaged mitochondria under stress.
Defects in Autophagy Upregulate p62
and ER Chaperones in Tumors
To assess whether the differential accumulation of p62, ER
chaperones and PDI was also a feature of autophagy defects
in tumors, Bcl-2-expressing atg5+/+ and atg5/, and beclin1+/+
and beclin1+/ iBMK tumor allografts, and spontaneous tumors
from beclin1+/mice were examined. As in iBMK cells with allelic
loss of beclin1 (Degenhardt et al., 2006; Mathew et al., 2007b),
deficiency in atg5 increased tumorigenesis and cooperated
with defects in apoptosis to accelerate tumor growth (Figures
3F and 3G). Bcl-2-expressing atg5/ tumors displayed elevated
p62, GRp170, GRp78, calnexin, and PDI compared to atg5+/+
tumors by Western blotting (Figure 3H) as did Bcl-2-expressing
beclin1+/ and atg5/ tumors by immunohistochemistry (IHC)
(data not shown). p62 was not transcriptionally upregulated in
beclin1+/ and atg5/ tumors as determined in the gene expres-
sion analysis (p62 mRNA expression varied between 0.9- and
1.3-fold among wild-type and autophagy-defective tumors)Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc. 1065
Figure 3. Autophagy Defects Promote ER Stress and Elevated DNA Damage Response in Tumors In Vivo
(A) Western blots showing levels of p62, ER chaperones, PDI and ubiquitin in Bcl-2-expressing beclin1+/+, beclin1+/, atg5+/+ and atg5/ iBMK cells following
5 or 7 days ofmetabolic stress, and 1 and 2 days of recovery. Values below the bands represent relative signal intensities compared to the basal protein level in the
first lane in each group (untreated Bcl-2-expressing beclin1+/+ and atg5+/+ control).
(B–D) Allelic loss of beclin1 sensitizes cells selectively to ER stress and proteasome inhibition. MTT assays showing sensitivity of Bcl-2-expressing beclin1+/+
(Blue) and beclin1+/ (Red) iBMK cells in response to increasing concentrations of (B) tunicamycin (3 days), or (C) epoxomicin (2 days), and (D) following
5 days of metabolic stress. Data are presented as mean ± SD.
(E) Autophagy deficiency causes mitochondrial damage. Western blots showing levels of mitochondrial proteins (ACO2, LON, SOD2 and PRDX3) in Bcl-2-
expressing beclin1+/+, beclin1+/, atg5+/+, and atg5/ iBMK cells, following metabolic stress.1066 Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc.
(data not shown). Upregulation of ubiquitinated proteins,
although common in tissues of autophagy-defective mice
(Hara et al., 2006; Komatsu et al., 2006), was not striking in
atg5/ tumors (Figure 3H). Additionally, tissues (lung, heart,
and liver) and spontaneous lung and liver tumors from 1.5
year-old beclin1+/ mice showed significant accumulation of
p62 and GRp170 when compared with age-matched tissues
from beclin1+/+ littermates (Figures 3I and 3J). Thus, allelic loss
of beclin1 and impaired autophagy caused elevated ER chap-
erone levels as a compensation mechanism and this phenotype
is manifested in tissues and spontaneous tumors.
While p62 and ER chaperone upregulation are common in
human tumors and are associated with poor prognosis, the
cause is unknown (Ni and Lee, 2007; Zatloukal et al., 2007).
Human hepatocellular carcinoma (HCC) is associated with p62
accumulation in Mallory-Denk bodies, and beclin1+/ mice
display p62 accumulation in liver in association with steatohepa-
titis and spontaneous liver tumors (Figure 3J) (Komatsu et al.,
2007; Qu et al., 2003; Yue et al., 2003), suggesting that autoph-
agy defects may play a prominent role in HCC etiology. Indeed,
liver and spontaneous liver tumors from beclin1+/ mice also
showed higher levels of p62, GRp170 and DNA damage
response activation (g-H2AX) compared to normal liver tissue
from age-matched beclin1+/+ mice (Figure 3J). p62, GRp170
and g-H2AX were examined in a panel of human liver and
HCCs in a tissue microarray (TMA). p62, GRp170, and g-H2AX
were upregulated with high frequency in HCC compared to
normal liver (Figure 3K). Thus, accumulation of p62 and
GRp170 in human tumors may be biomarkers for defective au-
tophagy manifesting as accumulation of unfolded proteins asso-
ciated with activation of the DNA damage response. Moreover,
failure of protein and organelle quality control caused by autoph-
agy defects may cause oxidative stress that is genotoxic.
Autophagy Mitigates Oxidative Stress
and Progression to Aneuploidy
Activation of the DNA damage response is a hallmark of oxida-
tive stress caused by ROS. Protein re-folding in the ER by PDIs
can elevate oxidative stress through redox reactions involving
free radicals (Tu and Weissman, 2004), and mitochondrial stress
and damage can also be a source of ROS (Fariss et al., 2005) in
autophagy-deficient cells. Since autophagy deficiency causes
accumulation of damaged mitochondria and the oxidative
protein folding machinery and activated DNA damage response,
we examined ROS levels in beclin1+/+ and beclin1+/ cells.Under normal growth conditions ROS levels were slightly
elevated in the beclin1+/ iBMK cells compared to the
beclin1+/+ cells, however, 5 days of metabolic stress caused
a marked ROS increase in beclin1+/ cells (Figures 4A and 4B).
During recovery, beclin1+/ iBMK cells showed increased ROS
that persisted for 24 hr compared to beclin1+/+ cells (Figures
4A and 4B). Thus allelic loss of beclin1 was associated with
elevated ROS production with stress.
To determine if the elevated ROS in autophagy-deficient cells
contributes to cellular damage, the stress response without and
with the ROS scavenger, N-acetyl cysteine (NAC) was examined.
Following 5 days of metabolic stress, beclin1+/ and atg5/
iBMK cells showed increased susceptibility to stress compared
to control cells (Figures 4C and S2) (Degenhardt et al., 2006; Kar-
antza-Wadsworth et al., 2007; Mathew et al., 2007b). The pres-
ence of NAC during metabolic stress improved survival, and
this protective effect was more profound in beclin1+/ and
atg5/ cells, suggesting that elevated ROS contribute to
increased susceptibility of autophagy-defective cells to stress
(Figures 4C and S2). This enhanced survival provided by NAC
was associated with decreased p62 accumulation during meta-
bolic stress in the beclin1+/ and atg5/ iBMK cells (Figure 4D
and S2), suggesting that ROS-mediated oxidative stress leads
to protein damage and accumulation of p62. A feature of
genomic instability associated with autophagy defects is the
accelerated progression to aneuploidy (Mathew et al., 2007b).
To examine the role of increased ROS levels on genomic insta-
bility, we monitored the DNA content of early passage diploid
beclin1+/+ and beclin1+/ iBMK cells without and with NAC.
beclin1+/+ cells maintained diploidy after 40 passages and the
presence of NAC had no effect. In contrast, beclin1+/ cells
showed accelerated progression to aneuploidy by passages
18 and 39 (Figure 4E), and NAC delayed this progression (Fig-
ure 4E), indicating a causative role for basal ROS-mediated
oxidative stress in progression to aneuploidy associated with
autophagy defects. Thus, metabolic stress causes p62 accumu-
lation mediated in part by elevated ROS production and the
failure to suppress ROS in autophagy-deficient cells is asso-
ciated with genomic instability.
p62 Accumulation Activates the DNADamage Response
Since autophagy deficiency leads to accumulation of p62, oxida-
tive stress and accelerated progression to aneuploidy, we exam-
ined if p62 accumulation was sufficient to induce ROS and
the DNA damage response. Transiently expressed p62-EGFP(F) Deficiency in atg5 in iBMK cells promotes tumorigenesis. Tumor allograft growth of atg5+/+ (red), atg5+/ (yellow), and atg5/ (blue) iBMK cell lines in
nude mice.
(G) Deficiency in atg5 cooperates with defective apoptosis and enhances tumor growth. Tumor allograft growth of Bcl-2-expressing atg5+/+ (red), and atg5/
(blue) iBMK cell lines in nude mice.
(H) Western blot showing elevated p62 and ER chaperones and PDI in Bcl-2-expressing atg5+/+ and atg5/ iBMK tumors in (G).
(I) Elevated p62 and GRp170 levels in lung and heart tissues and spontaneous lung tumors from beclin1+/ mice. Lung, heart and spontaneous lung tumor
sections from two 1.5-year-old beclin1+/+ and four 1.5-year-old beclin1+/mice were stained for p62 and GRp170 by IHC. Sections were independently scored
and analyzed by Student’s t test (lung) or Mann-Whitney test (heart) and a p < 0.05 was considered statistically significant.
(J) Elevated p62 and GRp170 in liver tissue and p62, Mallory-Denk bodies (H&E, arrows) and g-H2AX (arrows) in spontaneous liver tumors from beclin1+/mice
(1.5 years). Sections were independently scored and analyzed by Students t test for significance (p < 0.05).
(K) Elevated p62, GRp170, and g-H2AX positive nuclei in human HCC. Representative images from a human liver TMA (46 samples), showing H&E, p62, GRp170
and g-H2AX accumulation in HCCs. Representative images from a normal human liver TMA (14 samples) are shown for comparison. Sections were independently
scored and analyzed by Students t test for significance (p < 0.05).Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc. 1067
Figure 4. Metabolic Stress Promotes Elevated ROS Production and Chromosomal Instability in Autophagy-Deficient Cells
(A) Autophagy-deficiency leads to elevated ROS production. Overlays show ROS levels in Bcl-2-expressing beclin1+/+ (Green) and beclin1+/ iBMK cells (Blue)
(x axis, log scale) under normal growth (0Di) and at 0.5, 1, 2.5 and 24 hr (beclin1+/+, green arrows and beclin1+/, red arrows) during recovery (0.5-24hR) from
5 days of metabolic stress (5Di) by flow-cytometry using the ROS sensor DCF-DA. The ROS levels in untreated cells are shown in dotted lines for comparison.
(B) Representative histogram from three independent experiments measuring the mean ROS levels in Bcl-2-expressing beclin1+/+ and beclin1+/ iBMK cells
shown in (A).1068 Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc.
formed aggregates (Figure S1B) and elevated ROS in the au-
tophagy-deficient (beclin1+/ and atg5/) but not in beclin1+/+
and atg5+/+ iBMK cells, whereas EGFP expression alone did
not (Figures 5A and S1A). Transient p62-EGFP expression was
also associated with DNA damage response activation
(g-H2AX positive nuclear foci) in autophagy-deficient (beclin1+/
and atg5/) cells compared to beclin1+/+ and atg5+/+ cells
(Figures S1B and S1C). To monitor accumulation and clearance
of p62, apoptosis-deficient atg5+/+ and atg5/ iBMK cells
engineered to stably express either EGFP or p62-EGFP were
subjected to metabolic stress followed by recovery. As with
endogenous p62 (Figure 1B) and myc-p62 (Figure 1C), p62-
EGFP-expressing atg5/ iBMK cells displayed p62 aggregates
that were induced by metabolic stress and persisted in recovery
which atg5+/+ cells were able to eliminate (Figures 5B and 5C).
Consistent with transient expression (Figure S1B), stable p62-
EGFP expression activated the DNA damage response during
stress and recovery as indicated by g-H2AX positive nuclear
foci. While the focal pattern of g-H2AX staining characteristic
of DNA double strand breaks (Balajee and Geard, 2004) was
clear in majority of the g-H2AX positive nuclei, there were also
nuclei showing uniform g-H2AX staining indicating variations in
the levels of DNA damage. atg5/ iBMK cells expressing
EGFP showed markedly elevated levels of supernumerary
centrosomes compared to atg5+/+ cells under normal condi-
tions, but more strikingly so following stress and recovery.
Expression of p62-EGFP increased centrosome abnormalities
and multi-polar divisions, which were more dramatic under
stress and recovery in atg5/ compared to atg5+/+ cells (Figures
S1E and S1F). Thus p62 accumulation was sufficient for ROS
and DNA damage response induction under metabolic stress
leading to cell division abnormalities and genomic instability in
autophagy-defective cells. Indeed, RNAi-mediated knockdown
of p62 during metabolic stress reduced DNA damage induction
in autophagy-deficient beclin1+/ and atg5/ iBMK cells, further
suggesting that impaired p62 elimination was the cause of DNA
damage response activation (Figures 5D–5F).
p62 Promotes Tumorigenesis
of Autophagy-Defective Cells
Since p62 accumulates in tissues and tumors from autophagy-
deficient mice and in human cancers, we tested if p62 directly
contributed to tumorigenesis. Apoptosis-deficient atg5+/+ and
atg5/ iBMK cell lines expressing EGFP or p62-EGFP
(Figure 6A) were assessed for their tumorigenic potential. p62-
EGFPexpression inatg5+/+cell linesdidnot substantially increase
tumor growth (Figure 6B). In contrast, p62-EGFP expression in
atg5/ cells, dramatically increased tumor growth compared
to EGFP-expressing atg5/ controls (Figure 6B). In contrast to
EGFP-expressing atg5/ tumors displaying diffuse cytoplasmicEGFP localization and uniformly sized nuclei with occasional
appearance of tumor giant cells, p62-EGFP-expressing atg5/
tumors displayed dramatic p62 aggregate accumulation and
numerous pleomorphic tumor cells with heterochromatic, giant
nuclei by H&E staining indicative of polyploidy and aneuploidy
(Figure 6D). Persistent p62 accumulation in p62-EGFP-express-
ing atg5/ tumors was also associated with elevated DNA
damage response induction (g-H2AX) compared to EGFP-ex-
pressing atg5/ tumors (Figure 6D), suggesting that inability to
clear p62 through autophagy promoted tumor growth and
elevated DNA damage and genomic instability.
In addition to its role in binding and targeting polyubiquitinated
proteins to autophagosomes for lysosomal degradation, p62
also has a role as an adaptor protein regulating signal transduc-
tion in the RANKL, TrkA, and aPKC pathways through interac-
tions with TRAF6 and RIP1 that can regulate NF-kB (Moscat
et al., 2007; Wooten et al., 2008). To address the possibility
that deregulation of p62 in autophagy defective cells altered
cancer signaling pathways, global patterns of gene expression
where analyzed in atg5/ EGFP- and EGFP-p62-expressing
iBMK tumors (Figure 6). Of the 14,000 genes assessed, 893
genes (p = 0.05) displayed differential expression in EGFP-
compared with EGFP-p62-expressing tumors and were further
subjected to Ingenuity Pathway Analysis (IPA) and Gene Set
Enrichment Analysis (GSEA) (Figure 7A and Tables S2 and S3).
Both analyses indicated downregulation of host defense path-
ways including antigen presentation, Toll-like receptor and
Natural Killer (NK) cell mediated cytotoxicity pathways in
p62-EGFP- compared to EGFP-expressing tumors (Figure 7A
and Table S2). Interaction map analysis indicated that a
commonality in the pathways suppressed by p62 gain-of-func-
tion was the NF-kB pathway, and indeed NF-kB target genes
were downregulated in p62-EGFP compared to EGFP-express-
ing tumors (Table S3).
Allelic loss of beclin1 causes steatohepatitis, Mallory body
formation (p62 aggregates), and HCC (Figure 4E), which phen-
copies hepatocyte-targeted deficiency in NF-kB activators IKK-
b or NEMO (Luedde et al., 2007; Maeda et al., 2005). To test the
hypothesis that p62 gain-of-function was responsible for the
suppression of NF-kB, IL-6-luciferase reporter assays were
performed in autophagy-competent (beclin1+/+ and atg5+/+)
and autophagy-deficient (beclin1+/ and atg5/) iBMK cells in
response to TNF-a. Despite similar basal levels, autophagy-defi-
cient cells showed reduced NF-kB activation in response to
TNF-a, which was further inhibited by p62 expression (Figures
7B, 7C, and S3) suggesting that p62 accumulation impaired
NF-kB activation. In liver, deficient NF-kB canonical pathway
activation leads to impaired hepatocyte survival, Kupffer cell
activation and hepatomitogen (Il-6, TNF-a, hepatocyte growth
factor) production leading to non-canonical NF-kB pathway(C) ROS scavenging partially rescues the susceptibility to metabolic stress and recovery due to allelic loss of beclin1. Representative time-lapse images of
Bcl-2-expressing beclin1+/+ and beclin1+/ iBMK cells during recovery following 5 days of metabolic stress in presence (NAC) and absence (UT) of the ROS
scavenger NAC (1mM) (relative percentage of adherent cells compared to time 0 is shown).
(D) ROS scavenging suppresses p62 accumulation in autophagy-deficient (beclin1+/ and atg5/) cells. Western blot analysis of p62 levels in Bcl-2-expressing
beclin1+/+, beclin1+/, atg5+/+ and atg5/ iBMK cell lines following 0 or 7 days of metabolic stress followed by 1 day recovery without and with NAC.
(E) ROS scavenging limits progression to aneuploidy associated with allelic loss of beclin1. Flow-cytometry analysis of DNA content in diploid, Bcl-2-expressing
beclin1+/+ and beclin1+/ iBMK cells grown in presence (blue) or absence (red) of the ROS scavenger NAC (1mM). Numbers represent passage numbers at which
ploidy was determined.Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc. 1069
Figure 5. Failure to Eliminate p62 by Autophagy Activates the DNA Damage Response
(A) p62 expression leads to elevated ROS production in the autophagy-defective beclin1+/ cells. Bcl-2-expressing beclin1+/+ and beclin1+/ iBMK cells were
transfected with myc-tagged p62 or control vector and ROS levels (DCF-DA) were measured by flow-cytometry at day 3 posttransfection. Histogram on the right
is representative of three independent experiments measuring mean ROS level in each cell line on days 1 and 3 posttransfection.1070 Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc.
activation and compensatory proliferation of healthy hepatocyes
and toHCC. To test if defective autophagy andp62 accumulation
caused the same phenotype, nuclear localization of p50 NF-kB
indicative of activation was assessed in liver tissue from age-
matched beclin1+/+ and beclin1+/mice. Nuclear p50 and active
caspase-3were observed inmanybeclin1+/ liver and liver tumor
hepatocytes but not in beclin1+/+ livers (Figure 7D). Similarly,
p65 NF-kBwas frequently nuclear in beclin1+/ liver tumor hepa-
tocytes but was not nuclear in beclin1+/+ liver tissue (Figure 7E).
Importantly, p62accumulation in hepatocyteswasheterogenous
(Figure 3J). beclin1+/ hepatocytes that accumulated high p62
did not display nuclear p65 whereas those with less p62 showed
nuclear localization of p65 (Figure 7E). This suggests that as
in the IKKb- and NEMO-deficient hepatocyes, defective auto-
phagy and deregulation of p62 was associated with suppres-
sion of the canonical NF-kB pathway, impaired survival and
Figure 6. p62 Expression Cooperates with
Autophagy-Deficiency to Promote Tumor
Growth
(A) Western blot for EGFP, in Bcl-2-expressing
atg5+/+ and atg5/ iBMK cells stably expressing
EGFP or p62-EGFP.
(B) Tumor growth of cell lines in (A) showing
enhanced tumor growth in p62-EGFP expressing
atg5/ tumors (red) compared to that of the
control vector (yellow).
(C) Panel showing tumor-bearing mice injected
with p62-EGFP- (right panel), and EGFP- express-
ing (left panel)atg5/ iBMKcells from (B), at day74
postinjection.
(D) Tumors from p62-EGFP expressing atg5/
cells are associated with p62 aggregates and
polymorphic and g-H2AX positive nuclei. Repre-
sentative photomicrographs of frozen tumor
sections (left), and paraffin embedded sections
stained by H&E (middle) or IHC for g-H2AX (right)
[Student’s t test for significance (p < 0.05)] in
tumors from atg5/ cells shown in (C).
hepatomitogen-driven oncogenesis
through the non-canonical pathway.
Indeed, beclin1+/ livers and liver tumors
displayed increased TNF-a production
(Figure 7D).
DISCUSSION
Accumulation of p62 in response tometa-
bolic stress is a striking phenotype of au-
tophagy-defective tumors cells, suggest-
ing defective protein quality control may contribute to
tumorigenesis and that autophagy is the main mechanism by
which tumor cells turnover p62. Moreover, the failure of autoph-
agy-defective tumor cells to eliminate p62 was sufficient for
tumorigenesis. Unlike brain tissue (Hara et al., 2006; Komatsu
et al., 2006), there was no accumulation of polyubiquitinated
proteins in autophagy-defective tumor cells. There may be
tissue-specific differences in autophagy-mediated protein elimi-
nation or dilution of polyubiquitinated proteins through cell prolif-
eration in tumor cells may prevent their accumulation, which is
not possible in postmitotic neurons. Alternatively, proteasome-
mediated turnover of polyubiquitinated proteinsmay be elevated
in tumor cells compared to neuronal tissues. Indeed, autophagy
defects sensitized cancer cells to proteasome inhibitors, sug-
gesting a compensatory function of the two protein degradation
pathways.(B) Failure to eliminate p62 by autophagy under metabolic stress leads to DNA damage response induction. Bcl-2-expressing atg5+/+ or atg5/ iBMK cells stably
expressing EGFP or p62-EGFP were subjected to 3 days of metabolic stress, allowed to recover (1 day) and stained for g-H2AX.
(C) Quantitation of the percentage cells with g-H2AX positive foci in cells shown in (B). Data from 200 cells are presented as mean ± SD.
(D) Western blots of RNAi-knockdown of p62. Bcl-2-expressing wild-type (beclin1+/+ and atg5+/+) and autophagy-defective (beclin1+/ and atg5/) iBMK cells
were transfectedwith either Lamin- or p62-siRNA and subjected tometabolic stress for 0, 24, 48, or 72 hr (24, 48, 72, and 96 hr posttransfection, respectively) and
analyzed for p62 levels.
(E) p62 accumulation in autophagy-defective cells is responsible for activation of the DNA damage response. Cells in (D) were evaluated for g-H2AX positive
nuclear foci.
(F) Quantitation of percentage cells with g-H2AX positive nuclei from the data shown in (E). Data from two hundred cells are presented as mean ± SD.Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc. 1071
Figure 7. Accumulation of p62 in Autophagy-Defective Cells Alters Signal Transduction Pathways Involved in Host and Antioxidant Defense
(A) Pathways (p = 0.05; yellow line) suppressed in tumors from atg5/ iBMK cells expressing p62-EGFP compared to those expressing EGFP analyzed by IPA
(blue bars) and by GSEA (purple bars).
(B) Luciferase-reporter assays in Bcl-2 expressing wild-type (beclin1+/+) and autophagy-defective (beclin1+/) iBMK cells showing suppression of IL-6-Luciferase
reporter (NF-kB activity) in autophagy-defective cells by p62.
(C) Luciferase-reporter assays in Bcl-2 expressing beclin1+/+ iBMK (WB3) cells showing that overexpression of p62 is sufficient to suppress NF-kB transcriptional
activity in a concentration-dependant manner.1072 Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc.
The persistence of p62 and accumulation of ER chaperones
and the oxidative protein folding machinery in autophagy-defi-
cient cells and tumors indicated a defect in the management of
protein turnover. The inability to degrade damaged or misfolded
proteins through autophagy may increase the burden on the
ER protein folding machinery necessitating its upregulation.
Both p62 and GRp170 were dramatically upregulated in
beclin1+/ tissues as well as in spontaneous tumors, indicating
that coping with unfolded proteins may be a biomarker for
impaired autophagy that precedes tumor initiation. ER chaperone
and PDI upregulation are common in human tumors (Goplen et al.,
2006; Ni and Lee, 2007), and increased GRp170 expression is
associated with poor prognosis in breast cancer (Tamatani et al.,
2001). Although the cause of ER chaperone accumulation in
tumors was not known, chaperones are stress-responsive and
provide a protective function by suppressing the accumulation of
unfolded proteins that may be an important compensatory mech-
anism for autophagy-defective cells. Protein folding is a source of
oxidative stress (Tu and Weissman, 2004), particularly when cells
areoverburdenedwithdamagedandunfoldedproteins, inconcor-
dance with increased ROS in stressed beclin1+/ cells.
Stressed autophagy-defective tumor cells accumulate
damagedmitochondria as a potential additional source of oxida-
tive stress. This accumulation of unfolded protein and protein
aggregates and the persistence of damaged mitochondria may
collectively lead to elevated ROS production in autophagy-
defective cells. As ROS scavengers partially suppressed p62
accumulation and cell death in stressed beclin1+/ tumor cells,
the elevated oxidative stress may contribute to p62 induction,
cell damage and death. Although oxidative stress and DNA
damage arise through multiple genotoxic events (Halazonetis
et al., 2008), stress-mediated p62 accumulation in autophagy-
defective cellswas sufficient for ROSandDNAdamage response
induction that was prevented by knockdown of p62, establishing
that that elevated oxidative stresswas attributable directly to p62
accumulation. Enforced p62 expression induced ROS, suggest-
ing a possible amplification loop where oxidative stress induces
p62 accumulation, which in turn amplifies ROS generation.
Thus, the inability of autophagy-defective tumor cells to eliminate
p62 contributes to oxidative stress and likely to DNA damage.
These observations are strikingly similar to the rescue of oxida-
tive stress toxicity caused by atg7 deficiency with p62 deficiency
in mouse liver (Komatsu et al., 2007). In normal tissues, toxicity
due to p62 accumulation resulting from autophagy defect may
trigger cell death, whereas in checkpoint-defective tumor cells
this instead may also result in enhancement of mutations,
genome instability and tumor progression.
atg5/ tumors displayed pronounced p62 and p62 aggregate
accumulation and this p62 expression was sufficient to activatethe DNA damage response and to enhance tumor growth. p62
expression, p62 aggregates, and Mallory-Denk bodies contain-
ing p62 are common in steatosis and in HCC and other cancers
(Zatloukal et al., 2007). Defects in autophagy may be a mecha-
nism for sustained p62 accumulation and formation of Mallory-
Denkbodies.Assuch,p62accumulation isnotmerelyahistologic
marker for certain cancers, but rather, directly contributes to
tumor growth. While the prevalence of autophagy defects in
HCC is not yet known, mutations such as pten loss that constitu-
tively activates the PI3-kinase pathway and mTOR that inhibits
autophagy are common (Wong and Ng, 2008). Interestingly,
pten (Watanabe et al., 2005), beclin1, or atg7 deficiency (Ko-
matsu et al., 2007; Qu et al., 2003; Yue et al., 2003) produce liver
steatosis in mice suggesting that suppression of autophagy and
the resulting steatosis can lead to HCC.
How persistent p62 promotes oxidative stress and tumorigen-
esis appears to be related to its role as an adaptor protein
regulating receptor signaling and the activation of NF-kB. p62 is
also required for efficient oncogene activation in vitro and p62
deficiency suppresses spontaneous lung tumorigenesis by
K-ras (Duran et al., 2008). Thus, p62 has been identified as an on-
coprotein in both loss- (Duran et al., 2008) and gain-of-function
situations (Figure 6). p62 gain-of-function caused by defective
autophagy altered NF-kB signal transduction pathways that
regulate host defense. Whether p62 is upregulated and either
sequestered in non-functional aggregates inhibiting signal
transduction as indicated here, or is retained in an active state
enhancing signal transduction, may be cell type- or stress-
specific. In liver, defects in NF-kB canonical pathway activation
promote tumorigenesis by stimulation of inflammation and
activation of the non-canonical NF-kB pathway. However, this
function of NF-kBmay be tissue specific, and as NF-kB signaling
also regulates antioxidant defense, suppression of NF-kB by p62
mayexplain increasedoxidative stress in other autophagy-defec-
tive tissues. In conclusion, defects in autophagy promote a failure
of protein and organelle quality control in tumors this leads to p62
accumulation resulting in perturbation of gene expression,
increased oxidative stress, genome damage and tumorigenesis
(Figure 7F). As p62 upregulation is common in liver tissues of indi-
viduals at risk and hepatocellular carcinomas in patients, this
suggests that facilitating the clearance of p62 by promoting
autophagy may be a strategy for cancer chemoprevention.
EXPERIMENTAL PROCEDURES
Generation of Stable Cell Lines and Culture Conditions
atg5+/+, atg5+/, atg5/, beclin1+/+ and beclin1+/ iBMK cell lines were
described previously (Degenhardt et al., 2006; Degenhardt et al., 2002;
Mathew et al., 2008, 2007b). Bcl-2-expressing atg5+/+ and atg5/ iBMK cells,(D) Impaired hepatocyte survival, activation of NF-kB and cytokine production in beclin1+/ liver and beclin1+/ liver tumors. IHC staining showing elevated levels
apoptotic cell death (active caspase-3), NF-kB activation (nuclear p50), and cytokine production (TNF-a) in liver tissue and spontaneous liver tumors from
beclin1/ mice.
(E) Defective autophagy and accumulation of p62 suppress NF-kB activation and promotes HCC. Representative photomicrographs of frozen liver sections from
beclin1+/+ and beclin1+/ and spontaneous HCC from beclin1+/mice, immunostained for p62 (red) and p65NF-kB (green) and analyzed by confocalmicroscopy.
Note that those beclin1+/ hepatocytes that accumulate p62 do not display nuclear p65 (white arrows), whereas those without p62 display nuclear localization of
p65 indicative of NF-kB activation (yellow arrows).
(F) A model for the role of autophagy as a tumor suppressor mechanism by limiting p62 accumulation.Cell 137, 1062–1075, June 12, 2009 ª2009 Elsevier Inc. 1073
were engineered to stably express Myc-tagged p62 (pcDNA3-myc-p62),
EGFP (pEGFPC1) or p62-EGFP (pEGFPC1-p62) (Rodriguez et al., 2006), or
were cotransfected with pcDNA3-Zeo by electroporation as described
previously (Nelson et al., 2004). Independent clones were selected in zeocin
(1 mg/mL) and expanded as stable cell lines in normal culture conditions
(DMEM, 10% FBS, 1% Pen Strep (Invitrogen, Carlsband, CA) at 38.5C and
8.5%CO2) (Mathew et al., 2008). To inducemetabolic stress, cells were placed
in glucose-free DMEM (Invitrogen) containing 10% FBS and incubated with a
defined gasmixture containing 1%oxygen, 5%CO2 and 94%N2 (GTS-Welco,
Allentown, PA) (Nelson et al., 2004). NAC (Sigma-Aldrich, St. Louis, MO) was
used at a concentration of 1mM.
Proteomic Analysis by 2-DIGE and Mass Spectrometry
Total proteinswere isolated fromunstressedandmetabolically stressedBax//
Bak/ (D3), Bcl-2 expressing beclin1+/+(WB3), beclin1+/ (3BC2), atg5+/+
(6.1B2) and atg5/ (7.1B4) iBMK cell lines. Equal amounts of total proteins
were labeled with Cy3 (untreated) or Cy5 (stressed for 7 days), combined and
resolved on a single 2D analytical gel (Applied Biomics, inc., Hayward, CA).
Differential protein expressions (Cy5/Cy3)were quantitated usingDeCyder soft-
ware (Amersham,Piscataway,NJ). A total of 106spots thatwereeithermarkedly
induced (red) or repressed (green) were isolated from a parallel preparative gel
and protein IDs were determined by mass spectrometry (MALDI-TOF/TOF) for
protein identification.
Microarray Gene Expression Profiling and Pathway Analysis
Gene expression profile were performed on total mRNA isolated from tumors
from atg5/ Bcl-2 iBMK cells expressing p62-EGFP and EGFP proteins using
GeneChip Mouse Genome 430A 2.0 array (Affymetrix, Santa Clara, CA) as
described previously (Tsafrir et al., 2006). Raw data were refined using
Genes@Work USE-Fold feature selection (Tu et al., 2002) to identify a set of
893 genes differentially expressed in p62-EGFP tumors compared to EGFP
tumors (p = 0.05). These genes were then subjected to Gene Set Enrichment
Analysis (GSEA) (Mootha et al., 2003; Subramanian et al., 2005) to identify
pathways that are differentially regulated (p = 0.05). These genes were also
independently analyzed and mapped to canonical pathways using Ingenuity
Pathway Analysis (IPA) (Ingenuity Systems, Redwood City, CA). The signifi-
cance of association between the data set and the canonical pathways were
calculated based on the ratio of the number of genes from the data set that
map to the canonical pathway to the total number of genes in the pathway
and expressed as negative log p value using Fisher’s exact test.
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